# OnCo record allist (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/allist/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "allist" ;
  schema:name "Shanghai Allist Pharmaceuticals"@en ;
  schema:alternateName "Allist"@en, "艾力斯"@en ;
  schema:description "Allist is the single-product lung cancer company behind furmonertinib, China's other third-generation EGFR pill, partnered with ArriVent for the rest of the world."@en ;
  schema:url <https://onco.cc/companies/allist/>, <https://www.allist.com.cn/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.allist.com.cn/> ;
  onco:tag "china" ;
  schema:addressCountry "CN" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/furmonertinib/>, <https://onco.cc/drugs/sitneprotafib/> ;
  onco:trials <https://onco.cc/trials/furlong/>, <https://onco.cc/trials/nct06956001/>, <https://onco.cc/trials/nct05194995/>, <https://onco.cc/trials/nct05288205/>, <https://onco.cc/trials/nct05276726/>, <https://onco.cc/trials/nct04853342/>, <https://onco.cc/trials/nct05009329/>, <https://onco.cc/trials/nct06008288/>, <https://onco.cc/trials/nct05466149/>, <https://onco.cc/trials/nct06970639/> .